| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |